Preterm labour: Novel treatments

Drug Discovery Today: Therapeutic Strategies

Volumn 2, Issue 1, 2005, Pages 47-52

  Gullam, Joanna E ^a   Chatterjee, Jayanta ^b   Thornton, Steve ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HYDROXYPROGESTERONE CAPROATE; INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE; OXYTOCIN; OXYTOCIN RECEPTOR; PLACEBO; PROGESTERONE; PROGESTERONE RECEPTOR A; RITODRINE; SALBUTAMOL; TERBUTALINE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; LOW BIRTH WEIGHT; NONHUMAN; PERINATAL DEATH; PREMATURE LABOR; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TACHYPHYLAXIS; UTERUS CONTRACTION; VAGINA PESSARY;

EID: 21644437001     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2005.05.023     Document Type: Review

References (38)

1. P. Steer The epidemiology of preterm labour Br. J. Obstet. Gynaecol. 112 2005 1-3
2. K. Gyetavi et al. Tocolytics for preterm labour: A systematic review Obstet. Gynecol. 94 1999 869-877
3. S. Messiano et al. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium J. Clin. Endocrinol. Metab. 87 2002 2924-2930
4. P. Goldstein et al. A meta-analysis of randomized control trials of progestational agents in pregnancy Br. J. Obstet. Gynaecol. 96 1989 265-274
5. S. Daya Efficacy of progesterone support for pregnancy in women with recurrent miscarriage: A meta-analysis of controlled trials Br. J. Obstet. Gynaecol. 96 1989 275-280
6. M.J. Kierse Progesterone administration in pregnancy may prevent preterm delivery Br. J. Obstet. Gynaecol. 97 1990 149-154
7. Da Fonseca et al. Prophylactic administration of progesterone by vaginal suppositories to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomised placebo-controlled double-blinded study Am. J. Obstet. Gynecol. 188 2003 419-424
8. P.J. Meis et al. Prevention of recurrent preterm delivery by 17α-hydroxyprogesterone caproate N. Engl. J. Med. 348 2003 2379-2385
9. L.R. Brancazio et al. Progesterone and preterm delivery - deja vu all over again N. Engl. J. Med. 348 2003 2379-2385
10. L. Sanchez-Ramos et al. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials Obstet. Gynecol. 105 2005 273-279
11. A.M. Blanks et al. Paracrine oxytocin and estradiol demonstrate a spatial increase in human intrauterine tissue with labour J. Clin. Endocrinol. Metab. 88 2003 3392-3400
12. I sensitivity of human myometrium Am. J. Obstet. Gynecol. 190 2004 222-228
13. S. Kupittayanant et al. The effect of inhibiting Rho-associated kinase with Y-27632 on force and intracellular calcium in human myometrium Pflugers Arch. 443 2001 112-114
14. A.R. Fuchs et al. Oxytocin receptors in human parturition: A dual role for oxytocin in the initiation of labour Science 215 1984 1396-1398
15. R. Chibbar et al. Estrogen stimulates oxytocin gene expression in human chorio-decidua J. Clin. Endocrinol. Metab. 80 1995 567-572
16. T.M. Goodwin et al. The effects of the oxytocin antagonist atosiban on preterm uterine activity in the human Am. J. Obstet. Gynecol. 170 1994 474-478
17. M. Akerlund et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study Br. J. Obstet. Gynaecol. 94 1987 1040-1044
18. L.-F. Andersen et al. Oxytocin receptor blockade: A new principle in the treatment of preterm labour Am. J. Perinatol. 6 1989 196-199
19. T.M. Goodwin et al. Dose ranging study of the antagonist atosiban in the treatment of preterm labour Obstet. Gynecol. 88 1996 331-336
20. R. Romero et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labour: A randomised, double-blind, placebo-controlled trial with tocolytic rescue Am. J. Obstet. Gynecol. 182 2000 1173-1183
21. French/Australian Atosiban Investigators Group Treatment of preterm labour with the oxytocin antagonist atosiban: A double-blind, randomised, controlled comparison with salbutamol Eur. J. Obstet. Gynecol. Reprod. Biol. 98 2001 177-185
22. The European Atosiban Study Group The oxytocin antagonist atosiban versus the β-agonist terbutaline in the treatment of preterm labour. A randomised, double-blind, controlled study Acta Obstet. Gynecol. Scand. 80 2001 413-422
23. The Worldwide Atosiban versus Beta-agonists Study Group Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour Br. J. Obstet. Gynaecol. 108 2001 133-142
24. Thornton, S. et al. (2005) Clinical practice survey of Tractocile® (Atosiban) in preterm labour management in six European countries. The 7th World Congress on Controversies in Obstetrics, Gynaecology and Infertility, 14-17 April 2005, Athens, Greece (Abstract no. 294).
25. L.M.M. Duley Royal College of Obstetricians, Gynaecologists Tocolytic drugs for women in preterm labour Clinical Guidelines No. 1(B) 2002
26. A. Coomarasamy et al. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour; a meta-analysis with an indirect comparison of randomised trials Br. J. Obstet. Gynaecol. 110 2003 1045-1049
27. T.A. Johnston A.D. Cameron Atosiban for the primary prevention of preterm labour Br. J. Obstet. Gynaecol. 108 2001 886-887
28. C.A. Holleboom et al. Double-blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour Br. J. Obstet. Gynaecol. 103 1996 702-705
29. J.F. King Beta-mimietics in preterm labour: An overview of the randomised trials Br. J. Obstet. Gynaecol. 95 1988 211-222
30. Canadian Preterm Labour Investigators Group Treatment of preterm labour with the beta-adrenergic agonist ritodrine N. Engl. J. Med. 327 1992 308-312
31. J.F. King Calcium channel blockers for inhibiting preterm labour Cochrane Database Syst. Rev. 10.1002/14651858.CD002255 (Art. No.: CD002255)
32. D.N. Papatsonis et al. Nifedipine and ritodrine in the management of preterm labour: A randomised multicentre trial Obstet. Gynecol. 90 1997 230-234
33. H.P. van Geija et al. Nifedipine trials: Effectiveness and safety aspects Br. J. Obstet. Gynaecol. 112 2005 79-83
34. S.M. Cox et al. Randomised investigation of magnesium sulfate for prevention of preterm birth Am. J. Obstet. Gynecol. 163 1990 767-772
35. P.S. Ramsey D.J. Rouse Magnesium sulfate as a tocolytic agent Semin. Perinatol. 25 2001 248-255
36. R. Mittendorf P.G. Pryde A review of the role for magnesium sulphate in preterm labour Br. J. Obstet. Gynaecol. 112 2005 84-88
37. M. Eronen et al. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labour: A randomised double-blind study Am. J. Obstet. Gynecol. 164 1991 141-146
38. M.E. Norton et al. Neonatal complications after the administration of indomethacin for preterm labour N. Engl. J. Med. 329 1993 1602-1607